Literature DB >> 14960772

Molecular genetic analysis of the GJB1 gene: a study of six mutations.

Andrzej Kochański1, Dagmara Kabzińska.   

Abstract

Charcot-Marie-Tooth type X1 disease (CMTX1) is an X-dominant peripheral neuropathy caused by mutations in the GJB1 gene. Molecular genetic analysis of the GJB1 gene is crucial for CMTX1 diagnosis and for genetic counselling. To date, molecular genetic analysis of the GJB1 gene revealed 264 mutations in the GJB1 gene. In spite of the rising number of GJB1 gene mutations, family history was documented in only a few CMTX1 cases. The aim of this study was a molecular genetic analysis of the GJB1 gene in 7 families, performed in 19 CMTX1-affected patients and 13 healthy family members. Moreover, we attempted to report evidence of effects of 6 amino-acid substitutions described in this study. To the best of our knowledge, the G110D, V152D and K167E mutations are novel substitutions, which have not been reported so far.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960772

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  3 in total

1.  Asparagine 175 of connexin32 is a critical residue for docking and forming functional heterotypic gap junction channels with connexin26.

Authors:  So Nakagawa; Xiang-Qun Gong; Shoji Maeda; Yuhua Dong; Yuko Misumi; Tomitake Tsukihara; Donglin Bai
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

2.  Gap junction beta 1 (GJB1) gene mutations in Italian patients with X-linked Charcot-Marie-Tooth disease.

Authors:  Paola Mandich; Marina Grandis; Alessandro Geroldi; Massimo Acquaviva; Alessandra Varese; Rossella Gulli; Paola Ciotti; Emilia Bellone
Journal:  J Hum Genet       Date:  2008-04-01       Impact factor: 3.172

3.  Improving molecular diagnosis of Chinese patients with Charcot-Marie-Tooth by targeted next-generation sequencing and functional analysis.

Authors:  Li-Xi Li; Shao-Yun Zhao; Zhi-Jun Liu; Wang Ni; Hong-Fu Li; Bao-Guo Xiao; Zhi-Ying Wu
Journal:  Oncotarget       Date:  2016-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.